Peter F. Barnes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Peter F. Barnes has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Buka Samten
Univ Texas Hlth Sci Ctr Tyler, CPIDC, Tyler, TX 75708 USA
6 shared publicationsHomayoun Shams
Univ Texas Hlth Sci Ctr Tyler, CPIDC, Tyler, TX 75708 USA
6 shared publicationsBenjamin Wizel
Department of Microbiology and Immunology
4 shared publicationsDavid L. Lakey
Department of Microbiology and Immunology
3 shared publicationsStephen E. Weis
Center for Pulmonary and Infectious Disease Control, and Departments of Microbiology and Immunology and Medicine, University of Texas Health Center at Tyler, Tyler; Department of Internal Medicine, University of North Texas Health Science Center, Fort Worth, Texas; Nuffield Department of Clinical Medicine, University of Oxford, and John Radcliffe Hospital, Oxford, United Kingdom; and Statology, Ventura, California
3 shared publicationsPeter Klucar
Center for Pulmonary and Infectious Disease Control, and Departments of Microbiology and Immunology and Medicine, University of Texas Health Center at Tyler, Tyler; Department of Internal Medicine, University of North Texas Health Science Center, Fort Worth, Texas; Nuffield Department of Clinical Medicine, University of Oxford, and John Radcliffe Hospital, Oxford, United Kingdom; and Statology, Ventura, California
2 shared publications
Latest Publications
- 1 December 2009
- Published by Elsevier in Tuberculosis
- Vol. 89, S5-S9
Progress in understanding the human immune responses to Mycobacterium tuberculosis
- 1 December 2009
- Published by Elsevier in Tuberculosis
- Vol. 89, S5-S9
Progress in understanding the human immune responses to Mycobacterium tuberculosis
- 1 November 2005
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 172 (9) , 1161-1168
Enzyme-linked Immunospot and Tuberculin Skin Testing to Detect Latent Tuberculosis Infection
Rationale: Diagnosis of latent tuberculosis infection (LTBI) is currently based on the tuberculin skin test. The enzyme-linked immunospot assay (ELISPOT) is a new blood test to diagnose LTBI. Objective: To compare the ELISPOT and the tuberculin skin test for detecting LTBI in contacts of patients with tuberculosis. Methods: Prospective study of 413 contacts of patients with tuberculosis. Measurements and Main Results: Because there is no gold standard for LTBI, the sensitivity and specificity of the ELISPOT and tuberculin skin test cannot be directly measured. For each contact, we therefore estimated the likelihood of having LTBI by calculating a contact score that quantified exposure to and infectiousness of the index case. We analyzed the relationship of contact score to ELISPOT and tuberculin skin test results. The likelihood of a positive ELISPOT (p = 0.0005) and a tuberculin skin test (p = 0.01) increased significantly with rising contact scores. The contact score was more strongly related to the ELISPOT than to the tuberculin skin test results, although this difference was not statistically significant. Among U.S.-born persons and those who were not vaccinated with bacille Calmette-Guérin, approximately 30% had positive ELISPOT or tuberculin skin test results. Foreign-born, bacille Calmette-Guérin–vaccinated persons were significantly more likely to have a positive tuberculin skin test than a positive ELISPOT result (p < 0.0001). Conclusions: Compared with the tuberculin skin test, the ELISPOT appears to be at least as sensitive for diagnosis of LTBI in contacts of patients with tuberculosis.
- 1 November 2005
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 172 (9) , 1161-1168
Enzyme-linked Immunospot and Tuberculin Skin Testing to Detect Latent Tuberculosis Infection
Rationale: Diagnosis of latent tuberculosis infection (LTBI) is currently based on the tuberculin skin test. The enzyme-linked immunospot assay (ELISPOT) is a new blood test to diagnose LTBI. Objective: To compare the ELISPOT and the tuberculin skin test for detecting LTBI in contacts of patients with tuberculosis. Methods: Prospective study of 413 contacts of patients with tuberculosis. Measurements and Main Results: Because there is no gold standard for LTBI, the sensitivity and specificity of the ELISPOT and tuberculin skin test cannot be directly measured. For each contact, we therefore estimated the likelihood of having LTBI by calculating a contact score that quantified exposure to and infectiousness of the index case. We analyzed the relationship of contact score to ELISPOT and tuberculin skin test results. The likelihood of a positive ELISPOT (p = 0.0005) and a tuberculin skin test (p = 0.01) increased significantly with rising contact scores. The contact score was more strongly related to the ELISPOT than to the tuberculin skin test results, although this difference was not statistically significant. Among U.S.-born persons and those who were not vaccinated with bacille Calmette-Guérin, approximately 30% had positive ELISPOT or tuberculin skin test results. Foreign-born, bacille Calmette-Guérin–vaccinated persons were significantly more likely to have a positive tuberculin skin test than a positive ELISPOT result (p < 0.0001). Conclusions: Compared with the tuberculin skin test, the ELISPOT appears to be at least as sensitive for diagnosis of LTBI in contacts of patients with tuberculosis.
- 1 January 2005
- Published by American Society for Microbiology
- p. 489-496
Th1 and Th2 Cytokines in the Human Immune Response to Tuberculosis
- 1 January 2005
- Published by American Society for Microbiology
- p. 489-496
Th1 and Th2 Cytokines in the Human Immune Response to Tuberculosis
- Open Access
- 13 February 2004
- Published by Wiley in Molecular Microbiology
- Vol. 51 (6) , 1551-1562
The principal sigma factor sigA mediates enhanced growth of Mycobacterium tuberculosis in vivo
Summary: The ability of Mycobacterium tuberculosis to grow in macrophages is central to its pathogenicity. We found previously that the widespread 210 strain of M. tuberculosis grew more rapidly than other strains in human macrophages. Because principal sigma factors influence virulence in some bacteria, we analysed mRNA expression of the principal sigma factor, sigA, in M. tuberculosis isolates during growth in human macrophages. Isolates of the 210 strain had higher sigA mRNA levels and higher intracellular growth rates, compared with other clinical strains and the laboratory strain H37Rv. SigA was also upregulated in the 210 isolate TB294 during growth in macrophages, compared with growth in broth. In contrast, H37Rv sigA mRNA levels did not change under these conditions. Overexpression of sigA enhanced growth of recombinant M. tuberculosis in macrophages and in lungs of mice after aerosol infection, whereas recombinant strains expressing antisense transcripts to sigA showed decreased growth in both models. In the presence of superoxide, sense sigA transformants showed greater resistance than vector controls, and the antisense sigA transformant did not grow. We conclude that M. tuberculosis sigA modulates the expression of genes that contribute to virulence, enhancing growth in human macrophages and during the early phases of pulmonary infection in vivo. This effect may be mediated in part by increased resistance to reactive oxygen intermediates.
- 13 February 2004
- Published by Wiley in Molecular Microbiology
- Vol. 51 (6) , 1551-1562
Open AccessThe principal sigma factor sigA mediates enhanced growth of Mycobacterium tuberculosis in vivo
Summary: The ability of Mycobacterium tuberculosis to grow in macrophages is central to its pathogenicity. We found previously that the widespread 210 strain of M. tuberculosis grew more rapidly than other strains in human macrophages. Because principal sigma factors influence virulence in some bacteria, we analysed mRNA expression of the principal sigma factor, sigA, in M. tuberculosis isolates during growth in human macrophages. Isolates of the 210 strain had higher sigA mRNA levels and higher intracellular growth rates, compared with other clinical strains and the laboratory strain H37Rv. SigA was also upregulated in the 210 isolate TB294 during growth in macrophages, compared with growth in broth. In contrast, H37Rv sigA mRNA levels did not change under these conditions. Overexpression of sigA enhanced growth of recombinant M. tuberculosis in macrophages and in lungs of mice after aerosol infection, whereas recombinant strains expressing antisense transcripts to sigA showed decreased growth in both models. In the presence of superoxide, sense sigA transformants showed greater resistance than vector controls, and the antisense sigA transformant did not grow. We conclude that M. tuberculosis sigA modulates the expression of genes that contribute to virulence, enhancing growth in human macrophages and during the early phases of pulmonary infection in vivo. This effect may be mediated in part by increased resistance to reactive oxygen intermediates.
- 18 September 2003
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 349 (12) , 1149-1156
Molecular Epidemiology of Tuberculosis
The ability to determine the genotype of Mycobacterium tuberculosis is changing our understanding of the dynamics of tuberculosis transmission. This review summarizes the methods of genotyping and explains how they can assist clinical management. These techniques can be used to evaluate tuberculosis-control programs and provide clues to the pathogenesis of tuberculosis infection.
- 18 September 2003
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 349 (12) , 1149-1156
Molecular Epidemiology of Tuberculosis
The ability to determine the genotype of Mycobacterium tuberculosis is changing our understanding of the dynamics of tuberculosis transmission. This review summarizes the methods of genotyping and explains how they can assist clinical management. These techniques can be used to evaluate tuberculosis-control programs and provide clues to the pathogenesis of tuberculosis infection.
- Open Access
- 1 January 2003
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 36 (1) , 24-28
Serum Cytokine Concentrations Do Not ParallelMycobacterium tuberculosis–Induced Cytokine Production in Patients with Tuberculosis
We measured serum cytokine concentrations and Mycobacterium tuberculosis–stimulated cytokine production by peripheral blood mononuclear cells (PBMCs)
- 1 January 2003
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 36 (1) , 24-28
Open AccessSerum Cytokine Concentrations Do Not ParallelMycobacterium tuberculosis–Induced Cytokine Production in Patients with Tuberculosis
We measured serum cytokine concentrations and Mycobacterium tuberculosis–stimulated cytokine production by peripheral blood mononuclear cells (PBMCs)
- 1 August 2002
- Published by Microbiology Society in Microbiology
- Vol. 148 (8) , 2567-2572
Priming reverse transcription with oligo(dT) does not yield representative samples of Mycobacterium tuberculosis cDNA
Several recent publications have suggested that oligo(dT) can prime reverse transcription of several mycobacterial mRNAs. To determine if this is the case for most Mycobacterium tuberculosis mRNA species, reverse transcription reactions of M. tuberculosis RNA were primed with oligo(dT) or with other primers that did not target polyadenylylated sequences, and the resultant cDNA product was evaluated. Priming with oligo(dT) yielded more cDNA than priming with an arbitrary primer for only 1 of 12 unrelated M. tuberculosis genes, as measured by competitive PCR. Priming with oligo(dT) yielded cDNA for only 30% of the genes primed for by 37 M. tuberculosis genome-directed oligonucleotides, as assessed by hybridization of cDNA with an M. tuberculosis microarray. These data demonstrate that priming of reverse transcription of mycobacterial mRNA with oligo(dT) does not yield representative samples of cDNA.
- 1 August 2002
- Published by Microbiology Society in Microbiology
- Vol. 148 (8) , 2567-2572
Priming reverse transcription with oligo(dT) does not yield representative samples of Mycobacterium tuberculosis cDNA
Several recent publications have suggested that oligo(dT) can prime reverse transcription of several mycobacterial mRNAs. To determine if this is the case for most Mycobacterium tuberculosis mRNA species, reverse transcription reactions of M. tuberculosis RNA were primed with oligo(dT) or with other primers that did not target polyadenylylated sequences, and the resultant cDNA product was evaluated. Priming with oligo(dT) yielded more cDNA than priming with an arbitrary primer for only 1 of 12 unrelated M. tuberculosis genes, as measured by competitive PCR. Priming with oligo(dT) yielded cDNA for only 30% of the genes primed for by 37 M. tuberculosis genome-directed oligonucleotides, as assessed by hybridization of cDNA with an M. tuberculosis microarray. These data demonstrate that priming of reverse transcription of mycobacterial mRNA with oligo(dT) does not yield representative samples of cDNA.
- 1 March 2002
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 16 (1) , 107-126
Tuberculosis in patients with HIV infection
- 1 March 2002
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 16 (1) , 107-126
Tuberculosis in patients with HIV infection
- Open Access
- 1 May 2001
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 69 (5) , 3497-3501
Contribution of CD8+T Cells to Gamma Interferon Production in Human Tuberculosis
The proportions of peripheral blood mononuclear cells (PBMC), CD4+T cells, and CD8+T cells that produce gamma interferon (IFN-γ) in response toMycobacterium tuberculosiswere markedly reduced in tuberculosis patients, particularly in those with severe disease. Depletion of CD4+but not CD8+cells prior to stimulation of PBMC withM. tuberculosisabolished IFN-γ production. These results show that (i) IFN-γ production by CD8+and CD4+cells correlates with the clinical manifestations ofM. tuberculosisinfection and (ii) IFN-γ production by CD8+cells depends on CD4+cells.
- 1 May 2001
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 69 (5) , 3497-3501
Open AccessContribution of CD8+T Cells to Gamma Interferon Production in Human Tuberculosis
The proportions of peripheral blood mononuclear cells (PBMC), CD4+T cells, and CD8+T cells that produce gamma interferon (IFN-γ) in response toMycobacterium tuberculosiswere markedly reduced in tuberculosis patients, particularly in those with severe disease. Depletion of CD4+but not CD8+cells prior to stimulation of PBMC withM. tuberculosisabolished IFN-γ production. These results show that (i) IFN-γ production by CD8+and CD4+cells correlates with the clinical manifestations ofM. tuberculosisinfection and (ii) IFN-γ production by CD8+cells depends on CD4+cells.
- Open Access
- 1 February 2001
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 183 (3) , 478-484
Cytokine Profiles in Immunocompetent Persons Infected withMycobacterium aviumComplex
To evaluate the immunologic factors that contribute to protection against Mycobacterium avium complex (MAC), cytokine production by peripheral blood
- 1 February 2001
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 183 (3) , 478-484
Open AccessCytokine Profiles in Immunocompetent Persons Infected withMycobacterium aviumComplex
To evaluate the immunologic factors that contribute to protection against Mycobacterium avium complex (MAC), cytokine production by peripheral blood